Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Subasumstat |
Trade Name | |
Synonyms | TAK981|TAK 981|TAK-981 |
Drug Descriptions |
Subasumstat (TAK-981) is a small molecule inhibitor of SUMO, which may lead to activation of anti-tumor immune response (Cancer Res 2019;79(13 Suppl):Abstract nr 3252). |
DrugClasses | |
CAS Registry Number | 1858276-04-6 |
NCIT ID | C156270 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + Subasumstat | Avelumab Subasumstat | 0 | 1 |
Cetuximab + Subasumstat | Cetuximab Subasumstat | 0 | 1 |
Daratumumab and hyaluronidase-fihj + Subasumstat | Daratumumab and hyaluronidase-fihj Subasumstat | 0 | 1 |
Mezagitamab + Subasumstat | Mezagitamab Subasumstat | 0 | 1 |
Pembrolizumab + Subasumstat | Pembrolizumab Subasumstat | 0 | 1 |
Rituximab + Subasumstat | Rituximab Subasumstat | 0 | 1 |
Subasumstat | Subasumstat | 0 | 2 |